BACKGROUND: Sensorineural impairments and cardiovascular risk factors (CVRF) and disease (CVD) in midlife may be important predictors of future cognitive health, but longitudinal studies that include multiple sensorineural measures in middle-aged adults are lacking. METHODS: Hearing, vision, and olfaction, and CVRF and CVD were measured at the Beaver Dam Offspring Study baseline (2005-2008) examination. The Mini-Mental State Examination and Trail Making Tests A and B were administered at all phases and additional cognitive function measures were obtained at 5 (2010-2013) and 10 years (2015-2017). Cox proportional hazards models were used to evaluate associations between baseline sensorineural impairments, CVRF, CVD, and 10-year cumulative incidence of cognitive impairment and decline. RESULTS: There were 2,556 participants (22-84 years) without cognitive impairment at baseline and data from at least one follow-up. In a multivariable model including age, sex, education, and head injury, visual impairment (hazard ratio = 2.59, 95% confidence interval = 1.34, 5.02), olfactory impairment (hazard ratio = 3.18, 95% confidence interval = 1.53, 6.59), CVD (hazard ratio = 2.37, 95% confidence interval = 1.24, 4.52), and not consuming alcohol in the past year (hazard ratio = 2.21, 95% confidence interval = 1.16, 4.19) were associated with the 10-year cumulative incidence of cognitive impairment. Current smoking and diabetes were associated with increased risk, and exercise with decreased risk, of 10-year decline in cognitive function. CONCLUSIONS: Visual and olfactory impairments, CVRF, and CVD were associated with the 10-year cumulative incidence of cognitive impairment and decline in middle-aged adults. Identifying modifiable factors associated with cognitive decline and impairment in midlife may provide opportunities for prevention or treatment and improve cognitive health later in life.
BACKGROUND:Sensorineural impairments and cardiovascular risk factors (CVRF) and disease (CVD) in midlife may be important predictors of future cognitive health, but longitudinal studies that include multiple sensorineural measures in middle-aged adults are lacking. METHODS: Hearing, vision, and olfaction, and CVRF and CVD were measured at the Beaver Dam Offspring Study baseline (2005-2008) examination. The Mini-Mental State Examination and Trail Making Tests A and B were administered at all phases and additional cognitive function measures were obtained at 5 (2010-2013) and 10 years (2015-2017). Cox proportional hazards models were used to evaluate associations between baseline sensorineural impairments, CVRF, CVD, and 10-year cumulative incidence of cognitive impairment and decline. RESULTS: There were 2,556 participants (22-84 years) without cognitive impairment at baseline and data from at least one follow-up. In a multivariable model including age, sex, education, and head injury, visual impairment (hazard ratio = 2.59, 95% confidence interval = 1.34, 5.02), olfactory impairment (hazard ratio = 3.18, 95% confidence interval = 1.53, 6.59), CVD (hazard ratio = 2.37, 95% confidence interval = 1.24, 4.52), and not consuming alcohol in the past year (hazard ratio = 2.21, 95% confidence interval = 1.16, 4.19) were associated with the 10-year cumulative incidence of cognitive impairment. Current smoking and diabetes were associated with increased risk, and exercise with decreased risk, of 10-year decline in cognitive function. CONCLUSIONS:Visual and olfactory impairments, CVRF, and CVD were associated with the 10-year cumulative incidence of cognitive impairment and decline in middle-aged adults. Identifying modifiable factors associated with cognitive decline and impairment in midlife may provide opportunities for prevention or treatment and improve cognitive health later in life.
Authors: Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang Journal: Alzheimers Dement Date: 2014-07-09 Impact factor: 21.566
Authors: Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; James S Pankow; David M Nondahl Journal: Chem Senses Date: 2011-11-01 Impact factor: 3.160
Authors: M Kivipelto; E L Helkala; T Hänninen; M P Laakso; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen Journal: Neurology Date: 2001-06-26 Impact factor: 9.910
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Michael Y Lin; Peter R Gutierrez; Katie L Stone; Kristine Yaffe; Kristine E Ensrud; Howard A Fink; Catherine A Sarkisian; Anne L Coleman; Carol M Mangione Journal: J Am Geriatr Soc Date: 2004-12 Impact factor: 5.562
Authors: Carla R Schubert; Karen J Cruickshanks; David M Nondahl; Barbara E K Klein; Ronald Klein; Mary E Fischer Journal: JAMA Otolaryngol Head Neck Surg Date: 2013-10 Impact factor: 6.223
Authors: Natascha Merten; Adam J Paulsen; A Alex Pinto; Yanjun Chen; Lauren K Dillard; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Javier de la Fuente; Dario Moreno-Agostino; Alejandro de la Torre-Luque; A Matthew Prina; Josep María Haro; Francisco Félix Caballero; José Luis Ayuso-Mateos Journal: Gerontologist Date: 2020-07-15
Authors: Carla R Schubert; Mary E Fischer; A Alex Pinto; Adam J Paulsen; Yanjun Chen; Guan-Hua Huang; Barbara E K Klein; Michael Y Tsai; Natascha Merten; Karen J Cruickshanks Journal: Neurol Sci Date: 2022-09-17 Impact factor: 3.830
Authors: Yanjun Chen; Scott Hetzel; Alex A Pinto; Adam J Paulsen; Carla R Schubert; Laura M Hancock; Barbara E Klein; Natascha Merten; Karen J Cruickshanks Journal: Aging Clin Exp Res Date: 2022-03-10 Impact factor: 4.481
Authors: Jacqueline M Weycker; Lauren K Dillard; Alex Pinto; Mary E Fischer; Karen J Cruickshanks; Ted S Tweed Journal: Am J Audiol Date: 2021-11-03 Impact factor: 1.636
Authors: Humberto Parada; Gail A Laughlin; Mingan Yang; Frances R Nedjat-Haiem; Linda K McEvoy Journal: Age Ageing Date: 2021-06-28 Impact factor: 10.668
Authors: Natascha Merten; Mary E Fischer; Lauren K Dillard; Barbara E K Klein; Ted S Tweed; Karen J Cruickshanks Journal: J Speech Lang Hear Res Date: 2021-06-28 Impact factor: 2.297
Authors: Joshua R Ehrlich; Bonnielin K Swenor; Yunshu Zhou; Kenneth M Langa Journal: J Gerontol A Biol Sci Med Sci Date: 2021-11-15 Impact factor: 6.591